icon-folder.gif   Conference Reports for NATAP  
 
  64rd Annual Meeting of the
American Association for the
Study of Liver Diseases
Washington, DC Nov 1-5 2013
Back grey_arrow_rt.gif
 
 
 
New Monogram HCV Protease Inhibitor Resistance Test: "Cross-sectional Assessment of 1500 Clinical Samples Submitted for HCV NS3/4A Protease Inhibitor Drug Resistance Testing in the US"
 
 
  Reported by Jules Levin, AASLD Washington, DC, November 1-5, 2013
 
Sunny S. Choe, Joseph M. Volpe, Jacqueline D. Reeves, Wei Huang, Mojgan Haddad, Christos J. Petropoulos, and Charles M. Walworth* Monogram Biosciences, Inc. South San Francisco, CA, USA
 
New Protease Inhibitor (NS3/4A) Drug Resistance Test
http://www.natap.org/2011/HCV/080611_01.htm
 
LabCorp Introduces HCV Resistance Testing Through Monogram Biosciences With The Launch Of HCV GenoSure® NS3/4A
http://www.natap.org/2011/newsUpdates/090811_13.htm
 
AASLD/2011: Validation of an HCV NS3/4A Sequencing Assay for Evaluating Resistance to Boceprevir, Telaprevir and Protease Inhibitor Candidates in a Clinical Reference Laboratory Setting - (12/08/11)
 

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif